SHAKIL TUKDI: Open Payments
NPI 1215982723 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$846 in 40 payments from 8 companies in 2025. Trend: 2023 $340 · 2024 $169 · 2025 $846
Food & beverage: $846
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $313 |
| Corium, LLC | 9 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| ABBVIE INC. | 4 | $64 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Alkermes, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: COBENFY, Azstarys, CAPLYTA, TRINTELLIX, VRAYLAR, Auvelity, ARISTADA, SPRAVATO.
Industry payments across TX — which companies pay providers there.
